Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, … Read more
Shilpa Medicare Limited (SHILPAMED) - Total Liabilities
Latest total liabilities as of September 2025: ₹10.57 Billion INR
Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has total liabilities worth ₹10.57 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shilpa Medicare Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Shilpa Medicare Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shilpa Medicare Limited Competitors by Total Liabilities
The table below lists competitors of Shilpa Medicare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhuhai Huajin Capital Co Ltd
SHE:000532
|
China | CN¥772.99 Million |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥2.75 Billion |
|
Emdoor Information Co. Ltd. A
SHE:001314
|
China | CN¥1.82 Billion |
|
D&O Home Collection Co Ltd
SHE:002798
|
China | CN¥3.57 Billion |
|
Matrix Concepts Holdings Bhd
KLSE:5236
|
Malaysia | RM1.18 Billion |
|
AfreecaTV Co. Ltd
KQ:067160
|
Korea | ₩392.71 Billion |
|
Zhejiang Damon Technology Co Ltd
SHG:688360
|
China | CN¥1.98 Billion |
|
Guangzhou Devotion Therm Tech
SHE:300335
|
China | CN¥876.97 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Shilpa Medicare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shilpa Medicare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shilpa Medicare Limited (2006–2025)
The table below shows the annual total liabilities of Shilpa Medicare Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹9.47 Billion | -26.77% |
| 2024-03-31 | ₹12.93 Billion | +14.49% |
| 2023-03-31 | ₹11.30 Billion | +6.13% |
| 2022-03-31 | ₹10.64 Billion | -9.03% |
| 2021-03-31 | ₹11.70 Billion | +75.22% |
| 2020-03-31 | ₹6.68 Billion | +58.97% |
| 2019-03-31 | ₹4.20 Billion | +0.18% |
| 2018-03-31 | ₹4.19 Billion | -9.24% |
| 2017-03-31 | ₹4.62 Billion | +47.27% |
| 2016-03-31 | ₹3.14 Billion | -8.60% |
| 2015-03-31 | ₹3.43 Billion | +26.48% |
| 2014-03-31 | ₹2.71 Billion | +22.09% |
| 2013-03-31 | ₹2.22 Billion | +45.98% |
| 2012-03-31 | ₹1.52 Billion | +35.88% |
| 2011-03-31 | ₹1.12 Billion | -29.75% |
| 2010-03-31 | ₹1.60 Billion | -1.46% |
| 2009-03-31 | ₹1.62 Billion | +30.03% |
| 2008-03-31 | ₹1.24 Billion | +455.31% |
| 2007-03-31 | ₹224.19 Million | +116.46% |
| 2006-03-31 | ₹103.57 Million | -- |